Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of the Treatment Efficacy of High-Dose Corticosteroid and Tocilizumab During Clinical Worsening in Patients With COVID-19 Pneumonia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05133635
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:23.891945+00:00
Published At
2021-11-24T00:00:00+00:00
Record Updated At
2021-11-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["COVID-19 Virus Infection", "Cytokine Storm", "Corticosteroid", "Tocilizumab"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-11-24"
protocolSection.identificationModule.nctId
"NCT05133635"
protocolSection.identificationModule.officialTitle
"Comparison of the Treatment Efficacy of High-Dose Corticosteroid and Tocilizumab During Clinical Worsening in Patients With COVID-19 Pneumonia"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • COVID-19 Virus Infection (protocolSection.conditionsModule.conditions)
  • Cytokine Storm (protocolSection.conditionsModule.conditions)
  • Corticosteroid (protocolSection.conditionsModule.conditions)
  • Tocilizumab (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.